Cathie Wood ARK Investment Management
Cathie Wood is the founder, CEO, and CIO of ARK Investment Management, an investment firm known for its focus on “disruptive innovation”. She gained widespread attention for her bold market calls and high conviction in cutting-edge technologies such as electric vehicles, genomics, and blockchain. Under her guidance, ARK’s exchange-traded funds (ETFs) attracted substantial interest from both retail and institutional investors. Wood’s investment philosophy emphasizes research-driven analysis and long-term growth potential, positioning her as one of today’s most influential voices in the world of finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$94.6M |
| 2 |
JD.com
JD
|
+$52.3M |
| 3 |
CRISPR Therapeutics
CRSP
|
+$51.7M |
| 4 |
TWTR
Twitter, Inc.
TWTR
|
+$48.3M |
| 5 |
Baidu
BIDU
|
+$45.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ATHN
Athenahealth, Inc.
ATHN
|
+$82.2M |
| 2 |
Apple
AAPL
|
+$32.4M |
| 3 |
RDFN
Redfin
RDFN
|
+$27.3M |
| 4 |
XYZ
Block Inc
XYZ
|
+$25.8M |
| 5 |
Amazon
AMZN
|
+$25.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 31.78% |
| 2 | Technology | 26.07% |
| 3 | Communication Services | 15.57% |
| 4 | Consumer Discretionary | 14.57% |
| 5 | Financials | 3.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Ionis Pharmaceuticals
IONS
$9.93B
| $11.8M | 0.36% |
229,318
+16,191
| +8% | +$761K |
|
52
Adobe
ADBE
$109B
| $11.7M | 0.35% |
43,201
-191
| -0.4% | -$49.2K |
|
53
AeroVironment
AVAV
$8.14B
| $11.6M | 0.35% |
103,426
-50,184
| -33% | -$4.35M |
|
|
CLLS
54
Cellectis
CLLS
$342M
| $11.1M | 0.34% |
394,042
+149,779
| +61% | +$4.3M |
|
55
Inovio Pharmaceuticals
INO
$122M
| $10.7M | 0.32% |
159,756
+60,201
| +60% | +$3.35M |
|
56
Regeneron Pharmaceuticals
REGN
$85.9B
| $9.39M | 0.28% |
23,240
+4,658
| +25% | +$1.77M |
|
57
Trimble
TRMB
$14B
| $7.97M | 0.24% |
183,417
+24,061
| +15% | +$940K |
|
58
Biogen
BIIB
$32B
| $7.95M | 0.24% |
22,498
+8,448
| +60% | +$2.91M |
|
59
Teladoc Health
TDOC
$1.16B
| $7.75M | 0.23% |
89,791
-39,693
| -31% | -$2.83M |
|
|
ZUO
60
DELISTED
Zuora, Inc.
ZUO
| $6.92M | 0.21% |
299,269
+150,048
| +101% | +$4M |
|
61
Arcturus Therapeutics
ARCT
$382M
| $6.84M | 0.21% |
773,772
+239,999
| +45% | +$2M |
|
62
ServiceNow
NOW
$133B
| $6.49M | 0.2% |
165,760
-16,545
| -9% | -$626K |
|
|
MZOR
63
DELISTED
Mazor Robotics Ltd.
MZOR
| $6.14M | 0.19% |
105,304
+41,008
| +64% | +$2.19M |
|
64
Autodesk
ADSK
$53.6B
| $5.84M | 0.18% |
37,402
+3,455
| +10% | +$488K |
|
|
OPRA
65
Opera Ltd
OPRA
$1.7B
| $5.68M | 0.17% |
+631,887
| New | +$7.33M |
|
66
Intercontinental Exchange
ICE
$90.5B
| $5.16M | 0.16% |
68,927
+67,115
| +3,704% | +$5.05M |
|
67
Iovance Biotherapeutics
IOVA
$3.76B
| $4.78M | 0.14% |
424,820
+302,197
| +246% | +$4.29M |
|
68
Align Technology
ALGN
$11.5B
| $4.69M | 0.14% |
11,982
-2,239
| -16% | -$826K |
|
|
RUBY
69
DELISTED
Rubius Therapeutics, Inc
RUBY
| $4.52M | 0.14% |
+188,268
| New | +$4.3M |
|
70
Incyte
INCY
$25.9B
| $4.4M | 0.13% |
63,643
+19,719
| +45% | +$1.35M |
|
|
ANSS
71
DELISTED
Ansys
ANSS
| $4.01M | 0.12% |
21,497
+683
| +3% | +$122K |
|
72
Pluri
PLUR
$18.5M
| $3.76M | 0.11% |
36,153
+18,197
| +101% | +$1.88M |
|
|
BLCM
73
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
| $3.64M | 0.11% |
59,021
+30,644
| +108% | +$2.07M |
|
|
GRUB
74
DELISTED
Just Eat Takeaway.com N.V. American Depositary Shares
GRUB
| $3.58M | 0.11% |
+12,923
| New | +$3.33M |
|
|
JOYY
75
JOYY Inc
JOYY
$3.71B
| $3.51M | 0.11% |
+46,859
| New | +$3.94M |
|
Similar funds
Cathie Wood's Q3 2018 Portfolio in Review
As of Q3 2018, Cathie Wood held 218 positions worth $3.31B, up 21% from $2.73B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Cathie Wood deployed $446M of net new capital in Q3 2018, opening 18 new positions and adding to 100 existing holdings. Its largest new stake was Advanced Micro Devices: 640,180 shares worth $19.8M.
By sector, the portfolio is most concentrated in Healthcare at 32% of assets, up from 27% a quarter earlier, followed by Technology and Communication Services.
On the sell side, the largest reduction was Athenahealth, Inc., an estimated $82.2M trimmed.
- Cathie Wood's largest Q3 2018 buy was Advanced Micro Devices: 640,180 shares worth $19.8M.
- Cathie Wood added most to Tesla in Q3 2018, an estimated $94.6M increase.
- Cathie Wood's biggest Q3 2018 reduction was Athenahealth, Inc., cutting an estimated $82.2M.
- Cathie Wood fully exited Meta Platforms (Facebook) in Q3 2018, selling an estimated $12.8M.
- Cathie Wood's ten largest holdings make up 40% of its $3.31B portfolio in Q3 2018.
- Cathie Wood opened 18 new positions and closed 16 in Q3 2018.
- Cathie Wood's portfolio value rose 21% quarter-over-quarter to $3.31B.
Based on ARK Investment Management's 13F filing for Q3 2018, filed 7 Nov 2018.